A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions
Felipe García(Apple (Israel)), José M. Gatell(Universitat de Barcelona), Tomàs Pumarola(Universitat Autònoma de Barcelona), Teresa Gallart(Universitat de Barcelona), Mireia Arnedo(Escuela Nacional de Sanidad), Franco Lori(Research Institute for Genetic and Human Therapy), Montserrat Plana, Lucia Lopalco(Vita-Salute San Raffaele University), José M. Miró(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Gabriel M. Ortiz(Gladstone Institutes)
Cited by 51
Related Papers
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k
Treatment for Adult HIV Infection
|JAMA|2004|737
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2010|725